José Manuel
García Pinilla
Publications by the researcher in collaboration with José Manuel García Pinilla (25)
2024
-
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
European Journal of Heart Failure
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
2023
-
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
European Journal of Heart Failure, Vol. 25, Núm. 12, pp. 2316-2330
2022
-
Characterization of hereditary transthyretin cardiac amyloidosis in Spain
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495
-
Frailty and prognosis of older patients with chronic heart failure
Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019
-
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
The cardiomyopathies: from epidemiology to clinical work-up
European journal of preventive cardiology
2021
-
Determinants of maximal oxygen uptake in patients with heart failure
ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008
-
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224
2020
-
Consensus document and recommendations on palliative care in heart failure of the Heart Failure and Geriatric Cardiology Working Groups of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 69-77
-
Expert consensus statement on heart failure with reduced ejection fraction: beyond the guidelines
Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SB, pp. 1-46
-
Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323
-
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833
-
One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Oxygen therapy and palliative care in patients with heart failure. Response
Revista Espanola de Cardiologia
-
Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
2019
-
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
International Journal of Cardiology, Vol. 297, pp. 83-90
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
-
Selection of the best of 2018 in heart failure
REC: CardioClinics, Vol. 54, pp. 63-69
2018
-
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial
European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1128-1136